Phase Ib/Ii Study To Evaluate Safety And Tolerability Of Cabiralizumab In Combination With Nivolumab And Neoadjuvant Chemotherapy In Patients With Localized Triple-Negative Breast Cancer
Cabiralizumab;Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase Ib/Ii Study To Evaluate Safety And Tolerability Of Cabiralizumab In Combination With Nivolumab And Neoadjuvant Chemotherapy In Patients With Localized Triple-Negative Breast Cancer ### Output: Cabiralizumab;Nivolumab